MJ BIOTECH, INC.: 10-Q filed 2016-12-02
What MJ BIOTECH, INC. reported in its quarterly report filed 2016-12-02 (fiscal Q3 2016): 26 published measures, 71 facts as tagged in accession 0001543272-16-000103.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-12-02
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001543272-16-000103 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MJ BIOTECH, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 202,937 | USD | |
| At 2015-12-31 | 5,150 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,994,424 | USD | |
| At 2015-12-31 | 1,194,314 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 40 | USD | |
| At 2015-12-31 | 300 | USD | |
| At 2015-09-30 | 2,419 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | -1,811,006 | USD | 274 |
| 2015-01-01 to 2015-09-30 | -149,724 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | -44,469 | USD | 274 |
| 2015-01-01 to 2015-09-30 | -28,569 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 10,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 22,610 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 44,209 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 30,988 | USD | 273 |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 18,851,502 | shares | 92 |
| 2016-01-01 to 2016-09-30 | 15,027,530 | shares | 274 |
| 2015-07-01 to 2015-09-30 | 12,803,370 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 12,525,435 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 18,851,502 | shares | 92 |
| 2016-01-01 to 2016-09-30 | 15,027,530 | shares | 274 |
| 2015-07-01 to 2015-09-30 | 12,803,370 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 12,525,435 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -0.04 | USD/shares | 92 |
| 2016-01-01 to 2016-09-30 | -0.12 | USD/shares | 274 |
| 2015-07-01 to 2015-09-30 | 0 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | -0.01 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -0.04 | USD/shares | 92 |
| 2016-01-01 to 2016-09-30 | -0.12 | USD/shares | 274 |
| 2015-07-01 to 2015-09-30 | 0 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | -0.01 | USD/shares | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 2,897 | USD | |
| At 2015-12-31 | 4,850 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -900,908 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -1,349,623 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -34,071 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -135,192 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 200,040 | USD | |
| At 2015-12-31 | 300 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 80,136 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 283,809 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 1,906 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 31,828 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,994,424 | USD | |
| At 2015-12-31 | 1,194,314 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 900,908 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 1,349,623 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 44,071 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 157,802 | USD | 273 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 10,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 22,610 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 21,309,603 | shares | |
| At 2015-12-31 | 12,958,270 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 2,552,970 | USD | |
| At 2015-12-31 | 1,345,764 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -4,346,589 | USD | |
| At 2015-12-31 | -2,536,225 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -1,791,487 | USD | |
| At 2015-12-31 | -1,189,164 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 111,768 | USD | |
| At 2015-12-31 | 67,938 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -832,282 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -1,811,006 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -35,977 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -149,724 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 91,917 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 214,630 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 34,724 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 129,767 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 1,953 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 28,035 | USD | 273 |
Inspect the source
- Entity
- MJ BIOTECH, INC. / CIK 0001543272
- Captured
- SEC response SHA-256
b61db2c53d74121c10e90bbc0851e213984888202b0ea0e1ce29c973caeef086
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001543272.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))